A gut microbiota-based signature for predicting disease severity and recurrence risk in acute pancreatitis: a prospective cohort study
Accurate risk stratification remains challenging in acute pancreatitis (AP). Emerging evidence linked gut microbiota dysbiosis to AP progression, yet a definitive link between specific microbial profiles and the risk of severity transition or recurrence was lacking. This study aimed to identify and validate gut microbiota-based biomarkers for predicting disease severity and recurrence in AP. In this prospective cohort study, fecal samples were collected upon admission from 44 AP patients (24 mild, 20 moderately severe; 18 primary, 26 recurrent) and 20 age- and gender-matched healthy controls (HCs). Bacterial profiles were characterized via 16S rRNA gene sequencing of the V3–V4 hypervariable regions of bacterial communities. We employed random forest machine learning models to construct predictive biomarker panels, correlating differential taxa with clinical inflammatory markers (e.g., CRP, PCT) and severity scores (APACHE II, MCTSI). Functional pathways were predicted using Tax4Fun. Patients with MSAP exhibited significantly reduced α-diversity [Chao1 index: 275.21 (229.08, 412.59) vs. HC 324.77 (247.29, 503.26), p < 0.05] and distinct β-diversity clustering compared to MAP and HC groups. A targeted five-genus panel comprising Ruminococcus , Eubacterium_eligens_group , Lachnospiraceae_NK4A136_group , CAG_56, and Lachnospiraceae_UCG_010 effectively discriminated MSAP from MAP with an AUC of 0.833 (95% CI 0.553–1.000). For predicting recurrence, a three-genus panel demonstrated robust performance (AUC: 0.738, 95% CI 0.359–1.000). Notably, comparisons between AP subgroups and HCs exhibited significant enrichment of Fusobacterium , Veillonella , and Haemophilus , whereas the comparison between MAP and MSAP subgroups revealed marked depletion of beneficial commensal taxa. Functional profiling identified profound suppression of core microbial biosynthetic enzymes among MSAP subjects, concordant with elevated inflammatory markers and poor clinical outcomes. This study revealed a gut microbiota signature that reliably stratified AP progression and recurrence risk. Beyond mere taxonomy, we uncovered a functional depletion characteristic of disease severity, linking dysbiosis to systemic hyperinflammation. These findings positioned the gut microbiome as a valuable prognostic tool for risk assessment and potential for guiding microbiota-targeted interventions, moving towards precision management of acute pancreatitis.
Authors
- Yuanyuan Gou
- Jie Cao (ORCID: https://orcid.org/0000-0002-1963-8210)
- Qian Chen
- Long Yao
- Wenli Yang
- Bing He
Institutions
- Chongqing University (CN)
- Jiangjin Central Hospital (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1186/s40001-026-05409-2
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00